{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:10:46Z","timestamp":1791612646549,"version":"4.3.4"},"reference-count":175,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374368"],"award-info":[{"award-number":["82374368"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.intimp.2024.112769","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T04:54:00Z","timestamp":1722660840000},"page":"112769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges"],"prefix":"10.1016","volume":"140","author":[{"given":"Yadi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112769_b0005","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ndt\/gfq665","article-title":"The incidence of primary glomerulonephritis worldwide: a systematic review of the literature","volume":"26","author":"McGrogan","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2024.112769_b0010","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary Membranous Nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"CJASN"},{"key":"10.1016\/j.intimp.2024.112769_b0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.112769_b0020","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.112769_b0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.kint.2019.09.014","article-title":"Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy","volume":"97","author":"Sethi","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112769_b0030","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.kint.2019.07.014","article-title":"The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery","volume":"96","author":"Van De Logt","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112769_b0035","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(02)11042-7","article-title":"Rituximab for idiopathic membranous nephropathy","volume":"360","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.112769_b0040","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1681\/ASN.2016040449","article-title":"on behalf of the GEMRITUX Study Group, Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up","volume":"28","author":"Dahan","year":"2017","journal-title":"JASN"},{"key":"10.1016\/j.intimp.2024.112769_b0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa1814427","article-title":"Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy","volume":"381","author":"Fervenza","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.112769_b0050","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1681\/ASN.2020071091","article-title":"for the RI-CYCLO Investigators, Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial","volume":"32","author":"Scolari","year":"2021","journal-title":"JASN"},{"key":"10.1016\/j.intimp.2024.112769_b0055","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.kint.2020.10.014","article-title":"The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy","volume":"99","author":"Fern\u00e1ndez-Ju\u00e1rez","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112769_b0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3801","article-title":"The early history of B cells","volume":"15","author":"Cooper","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nri.2017.19","article-title":"Mechanisms of central tolerance for B cells","volume":"17","author":"Nemazee","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cellimm.2006.04.007","article-title":"Regulation of peripheral B cell maturation","volume":"239","author":"Thomas","year":"2006","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0075","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri2656","article-title":"The follicular versus marginal zone B lymphocyte cell fate decision","volume":"9","author":"Pillai","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0080","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.4049\/jimmunol.1001155","article-title":"Plasticity and Heterogeneity in the Generation of Memory B Cells and Long-Lived Plasma Cells: The Influence of Germinal Center Interactions and Dynamics","volume":"185","author":"Good-Jacobson","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0085","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.immuni.2021.07.015","article-title":"The unique biology of germinal center B cells","volume":"54","author":"Young","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112769_b0090","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B Cells: Origin, Phenotype, and Function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112769_b0095","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.iy.11.040193.001555","article-title":"T Cell-Dependent B Cell Activation","volume":"11","author":"Parker","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/cei\/uxac090","article-title":"Cytokine production by human B cells: role in health and autoimmune disease","volume":"210","author":"de Gruijter","year":"2022","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0105","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","article-title":"B lymphocytes: how they develop and function","volume":"112","author":"LeBien","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2024.112769_b0110","doi-asserted-by":"crossref","first-page":"13560","DOI":"10.3390\/ijms222413560","article-title":"B Cells in Primary Membranous Nephropathy: Escape from Immune Tolerance and Implications for Patient Management","volume":"22","author":"So","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.intimp.2024.112769_b0115","first-page":"495","article-title":"Immunoregulation in Heymann nephritis. I. Cell marker studies","volume":"70","author":"Cornish","year":"1989","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.intimp.2024.112769_b0120","first-page":"505","article-title":"Immunoregulation in Heymann nephritis. II. Functional studies","volume":"70","author":"Cornish","year":"1989","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.intimp.2024.112769_b0125","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1600-079X.2011.00960.x","article-title":"Melatonin enhances endogenous heme oxygenase-1 and represses immune responses to ameliorate experimental murine membranous nephropathy","volume":"52","author":"Wu","year":"2012","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.intimp.2024.112769_b0130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.kint.2017.01.012","article-title":"B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab","volume":"92","author":"Rosenzwajg","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112769_b0135","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/08916934.2017.1385775","article-title":"Higher frequencies of circulating ICOS +, IL-21 + T follicular helper cells and plasma cells in patients with new-onset membranous nephropathy","volume":"50","author":"Zhang","year":"2017","journal-title":"Autoimmunity"},{"key":"10.1016\/j.intimp.2024.112769_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2024.106838","article-title":"Alterations of B-Cell subsets in Peripheral Blood from Adult Patients with Idiopathic Membranous Nephropathy","volume":"266","author":"Wang","year":"2024","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2024.112769_b0145","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/rheumatology\/keq029","article-title":"Alterations on peripheral blood B-cell subpopulations in very early arthritis patients","volume":"49","author":"Moura","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.intimp.2024.112769_b0150","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.4049\/jimmunol.165.10.5970","article-title":"Disturbed Peripheral B Lymphocyte Homeostasis in Systemic Lupus Erythematosus","volume":"165","author":"Odendahl","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0155","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.ekir.2020.07.028","article-title":"A Comprehensive Phenotypic and Functional Immune Analysis Unravels Circulating Anti-Phospholipase A2 Receptor Antibody Secreting Cells in Membranous Nephropathy Patients","volume":"5","author":"Cantarelli","year":"2020","journal-title":"Kidney International Reports"},{"key":"10.1016\/j.intimp.2024.112769_b0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1523-1755.2000.00830.x","article-title":"Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy","volume":"57","author":"Mezzano","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112769_b0165","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0272-6386(89)80024-1","article-title":"Immune Mechanisms in Idiopathic Membranous Nephropathy: The Role of the Interstitial Infiltrates","volume":"13","author":"Alexopoulos","year":"1989","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.intimp.2024.112769_b0170","doi-asserted-by":"crossref","first-page":"1203062","DOI":"10.3389\/fimmu.2023.1203062","article-title":"Single-cell RNA sequencing shows the immune cell landscape in the kidneys of patients with idiopathic membranous nephropathy","volume":"14","author":"Shi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0175","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/joneph\/18.3.328","article-title":"CD20-positive infiltrates in human membranous glomerulonephritis","volume":"18","author":"Cohen","year":"2005","journal-title":"J. Nephrol."},{"key":"10.1016\/j.intimp.2024.112769_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108488","article-title":"B-cell oligoclonal expansions in renal tissue of patients with immune-mediated glomerular disease","volume":"217","author":"Kolovou","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.803929","article-title":"Characteristics and Prognostic Value of Tertiary Lymphoid Organs in Membranous Nephropathy: A Retrospective Study","volume":"8","author":"Wang","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.intimp.2024.112769_b0190","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri3700","article-title":"Ectopic lymphoid-like structures in infection, cancer and autoimmunity","volume":"14","author":"Pitzalis","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0195","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41581-023-00706-z","article-title":"The roles of tertiary lymphoid structures in chronic diseases","volume":"19","author":"Sato","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2024.112769_b0200","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1681\/ASN.2016010093","article-title":"Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China","volume":"27","author":"Xu","year":"2016","journal-title":"JASN"},{"key":"10.1016\/j.intimp.2024.112769_b0205","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3389\/fimmu.2020.01846","article-title":"Idiopathic Membranous Nephropathy: Glomerular Pathological Pattern Caused by Extrarenal Immunity Activity","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.860915","article-title":"Antigen Presentation in the Lung","volume":"13","author":"Kawasaki","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109412","article-title":"Cytokines network in primary membranous nephropathy","volume":"113","author":"Zhao","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112769_b0220","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.3389\/fimmu.2019.01809","article-title":"Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0225","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1681\/ASN.2016060644","article-title":"HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-Related Membranous Nephropathy","volume":"28","author":"Le","year":"2017","journal-title":"JASN"},{"key":"10.1016\/j.intimp.2024.112769_b0230","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1681\/ASN.2016020114","article-title":"MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy","volume":"28","author":"Cui","year":"2017","journal-title":"JASN"},{"key":"10.1016\/j.intimp.2024.112769_b0235","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/s41467-020-15383-w","article-title":"The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis","volume":"11","author":"Xie","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.112769_b0240","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.kint.2022.11.021","article-title":"Mapping the T cell epitopes of the M-type transmembrane phospholipase A2 receptor in primary membranous nephropathy","volume":"103","author":"Zhang","year":"2023","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112769_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.954936","article-title":"Role of B cells as antigen presenting cells","volume":"13","author":"Rastogi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0250","doi-asserted-by":"crossref","first-page":"eabb6296","DOI":"10.1126\/sciadv.abb6296","article-title":"B cells polarize pathogenic inflammatory T helper subsets through ICOSL-dependent glycolysis","volume":"6","author":"Zeng","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2024.112769_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.677036","article-title":"How Does B Cell Antigen Presentation Affect Memory CD4 T Cell Differentiation and Longevity?","volume":"12","author":"Welsh","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0260","article-title":"Global Characterization of Peripheral B Cells in Parkinson\u2019s Disease by Single-Cell RNA and BCR Sequencing","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0265","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2018.08.011","article-title":"Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis","volume":"175","author":"Jelcic","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.112769_b0270","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/imr.12859","article-title":"The role of B cell antigen presentation in the initiation of CD4+ T cell response","volume":"296","author":"Hua","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2024.112769_b0275","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.immunol.021908.132541","article-title":"B Cell Signaling and Fate Decision","volume":"28","author":"Kurosaki","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0280","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/416603a","article-title":"Chromatin\u2013IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors","volume":"416","author":"Leadbetter","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.112769_b0285","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1084\/jem.20050630","article-title":"RNA-associated autoantigens activate B cells by combined B cell antigen receptor\/Toll-like receptor 7 engagement","volume":"202","author":"Lau","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2024.112769_b0290","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41584-019-0211-0","article-title":"B cell checkpoints in autoimmune rheumatic diseases","volume":"15","author":"Rubin","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112769_b0295","doi-asserted-by":"crossref","first-page":"8963","DOI":"10.1074\/jbc.270.15.8963","article-title":"The Human 180-kDa Receptor for Secretory Phospholipases A2","volume":"270","author":"Ancian","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2024.112769_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102308","article-title":"Autoantigens PLA2R and THSD7A in membranous nephropathy share a common epitope motif in the N-terminal domain","volume":"106","author":"Fresquet","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2024.112769_b0305","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1681\/ASN.2014111061","article-title":"Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy","volume":"27","author":"Seitz-Polski","year":"2016","journal-title":"JASN"},{"key":"10.1016\/j.intimp.2024.112769_b0310","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1681\/ASN.2019030273","article-title":"Clinical Relevance of Domain-Specific Phospholipase A2 Receptor 1 Antibody Levels in Patients with Membranous Nephropathy","volume":"31","author":"Reinhard","year":"2020","journal-title":"JASN"},{"key":"10.1016\/j.intimp.2024.112769_b0315","doi-asserted-by":"crossref","first-page":"538","DOI":"10.5551\/jat.46284","article-title":"The Release of Monocyte-Derived Tissue Factor-Positive Microparticles Contributes to a Hypercoagulable State in Idiopathic Membranous Nephropathy","volume":"26","author":"Wang","year":"2019","journal-title":"JAT"},{"key":"10.1016\/j.intimp.2024.112769_b0320","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.immuni.2007.12.004","article-title":"Sites and Stages of Autoreactive B Cell Activation and Regulation","volume":"28","author":"Shlomchik","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112769_b0325","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.3390\/ijms21186712","article-title":"Toll-Like Receptor as a Potential Biomarker in Renal Diseases","volume":"21","author":"Mertowski","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.intimp.2024.112769_b0330","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7603\/s40681-014-0009-y","article-title":"Genetic susceptibility to idiopathic membranous nephropathy in high-prevalence Area, Taiwan","volume":"4","author":"Chen","year":"2014","journal-title":"BioMed"},{"key":"10.1016\/j.intimp.2024.112769_b0335","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/ndt\/gfg572","article-title":"Up-regulated interleukin-4 production by peripheral T-helper cells in idiopathic membranous nephropathy","volume":"19","author":"Masutani","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2024.112769_b0340","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.18632\/oncotarget.23232","article-title":"BAFF and APRIL expression as an autoimmune signature of membranous nephropathy","volume":"9","author":"Han","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2024.112769_b0345","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/ndt\/gfaa279","article-title":"Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults","volume":"36","author":"Oniszczuk","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2024.112769_b0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/8483650","article-title":"Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous Nephropathy","volume":"2019","author":"Netti","year":"2019","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2024.112769_b0355","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3181\/00379727-215-44119","article-title":"Cytokines Involved in B-Cell Differentiation and Their Sites of Action","volume":"215","author":"Takatsu","year":"1997","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.intimp.2024.112769_b0360","doi-asserted-by":"crossref","first-page":"77732","DOI":"10.18632\/oncotarget.12792","article-title":"Efficient generation of antigen-specific CTLs by the BAFF-activated human B Lymphocytes as APCs: a novel approach for immunotherapy","volume":"7","author":"Yiwen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2024.112769_b0365","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/modpathol.2012.237","article-title":"IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression","volume":"26","author":"Huang","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.intimp.2024.112769_b0370","doi-asserted-by":"crossref","first-page":"e0156263","DOI":"10.1371\/journal.pone.0156263","article-title":"Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy","volume":"11","author":"Dong","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112769_b0375","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0140-6736(97)04122-6","article-title":"Membranous nephropathy: an IgG4-mediated disease","volume":"351","author":"Oliveira","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.112769_b0380","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.635326","article-title":"The Diagnostic and Prognostic Potential of the B-Cell Repertoire in Membranous Nephropathy","volume":"12","author":"Su","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0385","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","article-title":"Follicular Helper T Cells","volume":"34","author":"Vinuesa","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0390","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular Helper CD4 T Cells (T FH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0395","article-title":"CXCR5, the Defining Marker for Follicular B Helper T (TFH) Cells","volume":"12","author":"Moser","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0400","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.immuni.2009.03.003","article-title":"Follicular Helper T Cells: Lineage and Location","volume":"30","author":"Fazilleau","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112769_b0405","article-title":"Helper T Cells in Idiopathic Membranous Nephropathy","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0410","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nature13300","article-title":"Clonal selection in the germinal centre by regulated proliferation and hypermutation","volume":"509","author":"Gitlin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.112769_b0415","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.immuni.2007.07.009","article-title":"Germinal-Center Organization and Cellular Dynamics","volume":"27","author":"Allen","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112769_b0420","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.intimp.2014.06.024","article-title":"Frequency of CD4+CXCR5+ TFH cells in patients with hepatitis b virus-associated membranous nephropathy","volume":"22","author":"Liu","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112769_b0425","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/1440-1681.12555","article-title":"Increased ratio of ICOS + \/ PD -1 + follicular helper T cells positively correlates with the development of human idiopathic membranous nephropathy","volume":"43","author":"Shi","year":"2016","journal-title":"Clin Exp Pharma Physio"},{"key":"10.1016\/j.intimp.2024.112769_b0430","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s12098-023-04815-2","article-title":"Follicular Helper T Cells and Follicular Regulatory T Cells Involved in Immune Disorders of Idiopathic Membranous Nephropathy","volume":"91","author":"Xu","year":"2024","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.intimp.2024.112769_b0435","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00011-023-01838-5","article-title":"Imbalance of T follicular helper cell subsets trigger the differentiation of pathogenic B cells in idiopathic membranous nephropathy","volume":"73","author":"Deng","year":"2024","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.intimp.2024.112769_b0440","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.2426","article-title":"Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions","volume":"17","author":"Chung","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2024.112769_b0445","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm.2425","article-title":"Foxp3+ follicular regulatory T cells control the germinal center response","volume":"17","author":"Linterman","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2024.112769_b0450","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.immuni.2014.12.006","article-title":"Regulatory T Cells Control Antigen-Specific Expansion of Tfh Cell Number and Humoral Immune Responses via the Coreceptor CTLA-4","volume":"41","author":"Wing","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112769_b0455","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1523-1755.2005.00415.x","article-title":"Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy","volume":"68","author":"Kuroki","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112769_b0460","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ki.1995.314","article-title":"Inhibition of the CD40-CD40ligand pathway prevents murine membranous glomerulonephritis","volume":"48","author":"Biancone","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112769_b0465","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3390\/cells11213391","article-title":"Aberrant B Cell Signaling in Autoimmune Diseases","volume":"11","author":"Corneth","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2024.112769_b0470","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.4049\/jimmunol.1001708","article-title":"BAFF Receptor Signaling Aids the Differentiation of Immature B Cells into Transitional B Cells following Tonic BCR Signaling","volume":"185","author":"Rowland","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0475","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.4049\/jimmunol.1800393","article-title":"Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells","volume":"201","author":"Du","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0480","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.4049\/jimmunol.179.6.3872","article-title":"Bruton\u2019s Tyrosine Kinase Mediates NF-\u03baB Activation and B Cell Survival by B Cell-Activating Factor Receptor of the TNF-R Family","volume":"179","author":"Shinners","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0485","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.immuni.2012.11.015","article-title":"The BAFF Receptor Transduces Survival Signals by Co-opting the B Cell Receptor Signaling Pathway","volume":"38","author":"Schweighoffer","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112769_b0490","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/imr.12810","article-title":"BAFF inhibition in SLE \u2013 is tolerance restored?","volume":"292","author":"Jackson","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2024.112769_b0495","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.coi.2008.03.015","article-title":"BAFF and the plasticity of peripheral B cell tolerance","volume":"20","author":"Stadanlick","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0500","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2004.05.010","article-title":"Excess BAFF Rescues Self-Reactive B Cells from Peripheral Deletion and Allows Them to Enter Forbidden Follicular and Marginal Zone Niches","volume":"20","author":"Thien","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112769_b0505","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1074-7613(04)00079-2","article-title":"Reduced Competitiveness of Autoantigen-Engaged B Cells due to Increased Dependence on BAFF","volume":"20","author":"Lesley","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112769_b0510","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1756-185X.2012.01814.x","article-title":"Comparative study on the level of B lymphocyte stimulator (B ly S) and frequency of lymphocytes between sero-negative and sero-positive rheumatoid arthritis patients","volume":"15","author":"Geng","year":"2012","journal-title":"Int J of Rheum Dis"},{"key":"10.1016\/j.intimp.2024.112769_b0515","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.clinbiochem.2006.09.010","article-title":"Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus","volume":"39","author":"Ju","year":"2006","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.intimp.2024.112769_b0520","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1681\/ASN.2021060784","article-title":"Molecular Characterization of Membranous Nephropathy","volume":"33","author":"Sealfon","year":"2022","journal-title":"JASN"},{"key":"10.1016\/j.intimp.2024.112769_b0525","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1038\/jid.2009.27","article-title":"Rituximab Mediates a Strong Elevation of B-Cell-Activating Factor Associated with Increased Pathogen-Specific IgG but Not Autoantibodies in Pemphigus Vulgaris","volume":"129","author":"Nagel","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2024.112769_b0530","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaut.2015.05.006","article-title":"Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab","volume":"62","author":"Mah\u00e9vas","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2024.112769_b0535","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrrheum.2011.1","article-title":"Long-lived autoreactive plasma cells drive persistent autoimmune inflammation","volume":"7","author":"Hiepe","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112769_b0540","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3389\/fimmu.2013.00494","article-title":"Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy","volume":"4","author":"Mah\u00e9vas","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0545","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2012030242","article-title":"Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy","volume":"23","author":"Hofstra","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.intimp.2024.112769_b0550","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ki.1997.32","article-title":"IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis","volume":"51","author":"Imai","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112769_b0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/7638365","article-title":"The Potential Role of Regulatory B Cells in Idiopathic Membranous Nephropathy","volume":"2020","author":"Dong","year":"2020","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2024.112769_b0560","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","article-title":"Immune Regulatory Function of B Cells","volume":"30","author":"Mauri","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0565","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jaci.2013.01.014","article-title":"IgG4 production is confined to human IL-10\u2013producing regulatory B cells that suppress antigen-specific immune responses","volume":"131","author":"Van De Veen","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0570","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.imlet.2023.08.001","article-title":"Elevated circulating CD19+CD24hiCD38hi B cells display pro-inflammatory phenotype in idiopathic membranous nephropathy","volume":"261","author":"Deng","year":"2023","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2024.112769_b0575","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112769_b0580","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/rheumatology\/keaa186","article-title":"Circulating CD19+CD24hiCD38hi regulatory B cells as biomarkers of response to methotrexate in early rheumatoid arthritis","volume":"59","author":"Fortea-Gordo","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.intimp.2024.112769_b0585","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112769_b0590","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-065X.2008.00661.x","article-title":"Regulatory B cells as inhibitors of immune responses and inflammation","volume":"224","author":"Bouaziz","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2024.112769_b0595","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.jid.2017.07.843","article-title":"The Unknown Aspect of BAFF: Inducing IL-35 Production by a CD5+CD1dhiFc\u03b3RIIbhi Regulatory B-Cell Subset in Lupus","volume":"137","author":"Zhang","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2024.112769_b0600","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2024.112769_b0605","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fimmu.2017.00110","article-title":"IL-10-Producing CD1dhiCD5+ Regulatory B Cells May Play a Critical Role in Modulating Immune Homeostasis in Silicosis Patients","volume":"8","author":"Chen","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0610","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ekir.2020.03.023","article-title":"Regulatory B Cells Are Reduced and Correlate With Disease Activity in Primary Membranous Nephropathy","volume":"5","author":"Ramachandran","year":"2020","journal-title":"Kidney International Reports"},{"key":"10.1016\/j.intimp.2024.112769_b0615","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/leu.2016.226","article-title":"Human memory B cells","volume":"30","author":"Seifert","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.intimp.2024.112769_b0620","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.2215\/CJN.05080610","article-title":"Rituximab Therapy in Idiopathic Membranous Nephropathy: A 2-Year Study","volume":"5","author":"Fervenza","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2024.112769_b0625","article-title":"The predictive and prognostic value of peripheral blood antigen-specific memory B cells in phospholipase A2 receptor-associated membranous nephropathy","author":"Zhu","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.intimp.2024.112769_b0630","doi-asserted-by":"crossref","first-page":"1308378","DOI":"10.3389\/fimmu.2023.1308378","article-title":"Human IgM-expressing memory B cells","volume":"14","author":"Budeus","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0635","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1681\/ASN.2015050523","article-title":"B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome","volume":"27","author":"Colucci","year":"2016","journal-title":"JASN"},{"key":"10.1016\/j.intimp.2024.112769_b0640","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/art.21617","article-title":"Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis","volume":"54","author":"Leandro","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.112769_b0645","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.kint.2019.12.025","article-title":"Anti-CD20\u2013mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives","volume":"97","author":"Crickx","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112769_b0650","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1172\/JCI65689","article-title":"B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells","volume":"123","author":"Mah\u00e9vas","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2024.112769_b0655","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/ndt\/gfad135","article-title":"Plasma cell\u2013directed therapy for rituximab-refractory PLA2R+ membranous nephropathy","volume":"38","author":"Salhi","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2024.112769_b0660","doi-asserted-by":"crossref","first-page":"7651024","DOI":"10.1155\/2016\/7651024","article-title":"Circulating (CD3\u2212CD19+CD20\u2212IgD\u2212CD27highCD38high) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?","volume":"2016","author":"Pozdzik","year":"2016","journal-title":"Mediators Inflamm."},{"issue":"2021","key":"10.1016\/j.intimp.2024.112769_b0665","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"Clinical Practice Guideline for the Management of Glomerular Diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112769_b0670","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/1060028018803587","article-title":"Rituximab Exhibits Altered Pharmacokinetics in Patients With Membranous Nephropathy","volume":"53","author":"Fogueri","year":"2019","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.intimp.2024.112769_b0675","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/ndt\/gfz041","article-title":"Rituximab bioavailability in primary membranous nephropathy","volume":"34","author":"Boyer-Suavet","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2024.112769_b0680","doi-asserted-by":"crossref","first-page":"1024068","DOI":"10.3389\/fimmu.2022.1024068","article-title":"Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives","volume":"13","author":"Hartinger","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0685","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2215\/CJN.0000000000000152","article-title":"Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy","volume":"18","author":"Teisseyre","year":"2023","journal-title":"CJASN"},{"key":"10.1016\/j.intimp.2024.112769_b0690","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.859419","article-title":"Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy","volume":"13","author":"Teisseyre","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0695","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.ki.5002628","article-title":"Rituximab treatment of idiopathic membranous nephropathy","volume":"73","author":"Fervenza","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112769_b0700","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.3389\/fimmu.2019.03069","article-title":"Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab","volume":"10","author":"Boyer-Suavet","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0705","doi-asserted-by":"crossref","first-page":"e232896","DOI":"10.1136\/bcr-2019-232896","article-title":"Ofatumumab for multirelapsing membranous nephropathy complicated by rituximab-induced serum-sickness","volume":"13","author":"Podest\u00e0","year":"2020","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.intimp.2024.112769_b0710","doi-asserted-by":"crossref","first-page":"1347880","DOI":"10.3389\/fphar.2024.1347880","article-title":"Case report: One case of refractory membranous nephropathy with hypokalemia after rituximab infusion was switched to obinutuzumab without recurrence of hypokalemia","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112769_b0715","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/ckj\/sfx072","article-title":"Rituximab-induced serum sickness in the treatment of idiopathic membranous nephropathy","volume":"11","author":"Cheong","year":"2018","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.intimp.2024.112769_b0720","doi-asserted-by":"crossref","first-page":"884","DOI":"10.24953\/turkjped.2020.05.025","article-title":"Rituximab-induced serum sickness and anaphylaxis in a child with nephrotic syndrome","volume":"62","author":"Bayram","year":"2020","journal-title":"Turk. J. Pediatr."},{"key":"10.1016\/j.intimp.2024.112769_b0725","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.760708","article-title":"The Risk of Severe Infections Following Rituximab Administration in Patients With Autoimmune Kidney Diseases: Austrian ABCDE Registry Analysis","volume":"12","author":"Odler","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0730","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/ndt\/gfx295","article-title":"Rituximab for non-responsive idiopathic membranous nephropathy in a Chinese cohort","volume":"33","author":"Wang","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2024.112769_b0735","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1053\/j.ajkd.2021.04.014","article-title":"Combination of Rituximab, Low-Dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up","volume":"78","author":"Zonozi","year":"2021","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.intimp.2024.112769_b0740","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.autrev.2016.02.014","article-title":"New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature","volume":"15","author":"Roccatello","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.112769_b0745","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/ard.2006.060772","article-title":"Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production","volume":"66","author":"Lavie","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.112769_b0750","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jaut.2015.11.002","article-title":"Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sj\u00f6gren\u2019s syndrome","volume":"67","author":"Cornec","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2024.112769_b0755","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/art.38074","article-title":"Elevated Serum BAFF Levels Are Associated With Rising Anti\u2013Double-Stranded DNA Antibody Levels and Disease Flare Following B Cell Depletion Therapy in Systemic Lupus Erythematosus","volume":"65","author":"Carter","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.112769_b0760","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.726428","article-title":"CyTOF-Enabled Analysis Identifies Class-Switched B Cells as the Main Lymphocyte Subset Associated With Disease Relapse in Children With Idiopathic Nephrotic Syndrome","volume":"12","author":"Fribourg","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0765","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/blood-2010-01-266668","article-title":"Am\u201cB\u201dvalent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis","volume":"116","author":"Thaunat","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2024.112769_b0770","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2215\/CJN.03950412","article-title":"Decreased CD5+ B Cells in Active ANCA Vasculitis and Relapse after Rituximab","volume":"8","author":"Bunch","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2024.112769_b0775","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000501858","article-title":"Accelerating the Depletion of Circulating Anti-Phospholipase A2 Receptor Antibodies in Patients with Severe Membranous Nephropathy: Preliminary Findings with Double Filtration Plasmapheresis and Ofatumumab","volume":"144","author":"Podest\u00e0","year":"2020","journal-title":"Nephron"},{"key":"10.1016\/j.intimp.2024.112769_b0780","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ekir.2021.01.022","article-title":"Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy","volume":"6","author":"Teisseyre","year":"2021","journal-title":"Kidney International Reports"},{"key":"10.1016\/j.intimp.2024.112769_b0785","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.ajkd.2023.08.010","article-title":"Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series","volume":"83","author":"Podest\u00e0","year":"2024","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.intimp.2024.112769_b0790","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.ekir.2020.06.030","article-title":"Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy","volume":"5","author":"Sethi","year":"2020","journal-title":"Kidney International Reports"},{"key":"10.1016\/j.intimp.2024.112769_b0795","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/j.ajkd.2020.02.444","article-title":"Successful Treatment of Patients With Refractory PLA2R-Associated Membranous Nephropathy With Obinutuzumab: A Report of 3 Cases","volume":"76","author":"Klomjit","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.intimp.2024.112769_b0800","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/ckj\/sfab250","article-title":"Membranous nephropathy associated with immunoglobulin G4-related disease successfully treated with obinutuzumab","volume":"15","author":"Ginth\u00f6r","year":"2022","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.intimp.2024.112769_b0805","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12882-022-02761-3","article-title":"Treatment resistant M-type phospholipase A2 receptor associated membranous nephropathy responds to obinutuzumab: a report of two cases","volume":"23","author":"Hudson","year":"2022","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.intimp.2024.112769_b0810","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ekir.2023.01.035","article-title":"Obinutuzumab in Refractory Phospholipase A2 receptor-Associated Membranous Nephropathy With Severe CKD","volume":"8","author":"Naik","year":"2023","journal-title":"Kidney International Reports"},{"key":"10.1016\/j.intimp.2024.112769_b0815","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00467-023-06085-8","article-title":"A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance","volume":"39","author":"Conversano","year":"2024","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.intimp.2024.112769_b0820","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s40620-020-00874-2","article-title":"Successful treatment of PLA2R1-antibody positive membranous nephropathy with ocrelizumab","volume":"34","author":"Schmidt","year":"2021","journal-title":"J. Nephrol."},{"key":"10.1016\/j.intimp.2024.112769_b0825","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/ndt\/gfz086","article-title":"Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy","volume":"35","author":"Barrett","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2024.112769_b0830","doi-asserted-by":"crossref","first-page":"1268929","DOI":"10.3389\/fimmu.2023.1268929","article-title":"Case report: Successful treatment of refractory membranous nephropathy with telitacicept","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112769_b0835","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40620-013-0028-x","article-title":"Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy","volume":"27","author":"Hartono","year":"2014","journal-title":"J. Nephrol."},{"key":"10.1016\/j.intimp.2024.112769_b0840","first-page":"350","article-title":"Bortezomib as a Novel Approach to Early Recurrent Membranous Glomerulonephritis After Kidney Transplant Refractory to Combined Conventional Rituximab Therapy","volume":"15","author":"Barbari","year":"2017","journal-title":"Exp. Clin. Transplant."},{"key":"10.1016\/j.intimp.2024.112769_b0845","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.kint.2021.04.011","article-title":"Bortezomib plus dexamethasone for rituximab-resistant PLA2R+ membranous nephropathy","volume":"100","author":"Salhi","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112769_b0850","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000515087","article-title":"Bortezomib Treatment for Refractory PLA2R-Positive Membranous Nephropathy","volume":"1","author":"Geara","year":"2021","journal-title":"Glomerular Dis"},{"key":"10.1016\/j.intimp.2024.112769_b0855","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.kint.2021.12.019","article-title":"Daratumumab for multidrug-resistant phospholipase-A2 receptor\u2013related membranous nephropathy","volume":"101","author":"Vink","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112769_b0860","doi-asserted-by":"crossref","first-page":"e14263","DOI":"10.1111\/petr.14263","article-title":"A case of treatment-resistant membranous nephropathy associated with graft versus host disease successfully treated with daratumumab","volume":"26","author":"Benoit","year":"2022","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.intimp.2024.112769_b0865","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.kint.2021.11.001","article-title":"Anti-CD38 therapy for PLA2R-positive membranous nephropathy resistant to conventional immunosuppression","volume":"101","author":"Stehl\u00e9","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112769_b0870","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.kint.2024.01.021","article-title":"An antigen-specific chimeric autoantibody receptor (CAAR) NK cell strategy for the elimination of anti-PLA2R1 and anti-THSD7A antibody-secreting cells","volume":"105","author":"Seifert","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112769_b0875","doi-asserted-by":"crossref","first-page":"1335998","DOI":"10.3389\/fimmu.2024.1335998","article-title":"Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases","volume":"15","author":"Perico","year":"2024","journal-title":"Front. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924012906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924012906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:08:00Z","timestamp":1786363680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924012906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":175,"alternative-id":["S1567576924012906"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112769","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112769"}}